Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1197
152884_Heymach_J1.jpg

Article ID: 701027

Poziotinib Maintains High Response Rate Against Harmful Lung Cancer Mutation

University of Texas M. D. Anderson Cancer Center

A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates among stage 4 non-small cell lung cancer patients with genetic mutations that have previously defied treatment.

Released:
24-Sep-2018 4:05 PM EDT
Embargo will expire:
26-Sep-2018 2:00 PM EDT
Released to reporters:
24-Sep-2018 11:10 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 26-Sep-2018 2:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

  • Embargo expired:
    24-Sep-2018 10:30 AM EDT

Article ID: 700842

Study Shows Invasive Lung Cancer Surgery Can Lead to Long-term Opioid Use

Mount Sinai Health System

Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more likely to become chronic opioid users than patients treated with minimally invasive surgery.

Released:
20-Sep-2018 12:05 PM EDT
Bob.Doebele.2018.iv.jpg
  • Embargo expired:
    24-Sep-2018 9:45 AM EDT

Article ID: 700973

Promising Phase 1/2 Results for Entrectinib Against ROS1+ Non-Small Cell Lung Cancer

University of Colorado Cancer Center

Results of phase 1 and phase 2 clinical trials of the drug entrectinib in ROS1-positive non-small cell lung cancer (NSCLC) presented on the press program of the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer show a response rate of 77.4 percent for 53 patients evaluable for response, with median duration of response of 24.6 months.

Released:
24-Sep-2018 8:45 AM EDT

Article ID: 700925

تقدم مبادئ توجيهية جديدة لمرض الانسداد الرئوي المزمن من الهيئة الدولية توصيات مُحدّثة

Mayo Clinic

روتشستر، مينيسوتا - يعتبر مرض الانسداد الرئوي الزمن (COPD) بالنسبة لكثير من الناس مرضًا مؤلمًا ومتكررًا يؤثر على القدرة على التنفس وجودة الحياة. بالرغم من كون مرض الانسداد الرئوي المزمن مرضًا من الممكن علاجه، إلا أنه يبقى السبب الثالث المؤدي للوفاة في الولايات المتحدة الأمريكية. وفي الإصدار الأخير لمجلة Mayo Clinic Proceedings، يلقي الباحثون نظره فاحصه عن كثب على النتائج والتوصيات الجديدة للمبادرة العالمية لمرض الانسداد الرئوي المزمن (GOLD) لتقييم آخر التطورات والنظر في دور العلاج بالنسبة لهذا المرض.

Released:
21-Sep-2018 12:05 PM EDT

Article ID: 700920

国际小组的新COPD指南提供了最新的建议

Mayo Clinic

对于许多人来说,慢性阻塞性肺病(chronic obstructive pulmonary disease, COPD)是一种令人痛苦和极易复发的疾病,会严重影响呼吸能力和生活质量。 虽然可以治疗,但COPD仍然是美国人的第三大死因。在最新一期的Mayo Clinic Proceedings里,研究人员仔细研究了全球慢性阻塞性肺病倡议(Global Initiative for Chronic Obstructive Lung Disease, GOLD)的新发现和建议,以评估这些更新,以及治疗在疾病中的作用。

Released:
21-Sep-2018 12:05 PM EDT

Article ID: 700923

Novas diretrizes do painel internacional para DPOC fornecem recomendações atualizadas

Mayo Clinic

Para muitas pessoas, a doença pulmonar obstrutiva crônica (DPOC) é uma doença angustiante e recorrente que afeta a capacidade de respiração e a qualidade de vida. Embora possua tratamento, a DPOC continua sendo a terceira maior causa de morte nos EUA. Na última edição da Mayo Clinic Proceedings, pesquisadores analisaram atentamente as descobertas e recomendações da Iniciativa Global para a Doença Pulmonar Obstrutiva Crônica (GOLD) para avaliar suas atualizações e identificar o papel do tratamento desta doença.

Released:
21-Sep-2018 12:05 PM EDT
cookingonwoodstove.jpg
  • Embargo expired:
    21-Sep-2018 12:15 AM EDT

Article ID: 700647

Cooking with Wood or Coal Is Linked to Increased Risk of Respiratory Illness and Death

American Thoracic Society (ATS)

Burning wood or coal to cook food is associated with increased risk of hospitalization or dying from respiratory diseases, according to new research conducted in China and published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released:
17-Sep-2018 4:00 PM EDT

Article ID: 700854

Panel internacional para la Enfermedad Pulmonar Obstructiva Crónica ofrece recomendaciones actualizadas

Mayo Clinic

Para algunas personas, la Enfermedad Pulmonar Obstructiva Crónica (EPOC) es una enfermedad recurrente y angustiante que afecta la capacidad de respirar y la calidad de vida. Aunque es una enfermedad que puede tratarse, la Enfermedad Pulmonar Obstructiva Crónica continúa siendo la tercera causa de muerte en los Estados Unidos. En la última edición de Mayo Clinic Proceedings, los investigadores revisan de cerca los nuevos hallazgos y recomendaciones de la Iniciativa Global para la Enfermedad Pulmonar Obstructiva Crónica (GOLD, por sus siglas en inglés) para evaluar la información actualizada y abordar el rol del tratamiento en la enfermedad.

Released:
20-Sep-2018 12:05 PM EDT
MichelleHernandez.jpg

Article ID: 700831

UNC School of Medicine Study Shows Surprise Low-level Ozone Impact on Asthma Patients

University of North Carolina Health Care System

A new study led by UNC School of Medicine researchers indicates that ozone has a greater impact on asthma patients than previously thought.

Released:
20-Sep-2018 11:05 AM EDT

Showing results

110 of 1197

Chat now!